1 November 2024
Marlowe plc
Total Voting Rights
In accordance with section 5.6.1 of the Financial Conduct Authority's (FCA) Disclosure Guidance and Transparency Rules (DTRs), Marlowe plc ("Marlowe" or the "Group") hereby notifies the market of the following:
The Group's issued capital as at 31 October 2024 consists of 85,689,727 ordinary shares of 50p each ("Ordinary Shares") with voting rights attached. Of these, no Ordinary Shares are held exclusive of voting rights in Treasury.
Therefore, the total number of voting rights in Marlowe as at 31 October 2024 is 85,689,727.
Shareholders may use the figure of 85,689,727 Ordinary Shares as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in Marlowe under the DTRs.
|
For further information: |
|
|
|
|
|
Marlowe plc |
|
|
Lord Ashcroft, Interim Non-Executive Chair Adam Councell, Chief Financial Officer Benjamin Tucker, Head of Investor Relations & Strategy |
www.marloweplc.com Tel: +44 (0)20 3813 8498
|
|
Cavendish Capital Markets Limited (Nominated Adviser & Joint Broker) |
|
|
Ben Jeynes George Lawson |
Tel: +44 (0)20 7220 0500 |
|
|
|
|
Investec Bank (Joint Broker) |
|
|
Henry Reast Oliver Cardigan |
Tel: +44 (0)20 7597 5970 |
|
FTI Consulting |
|
|
Nick Hasell Alex Le May |
Tel: +44 (0)20 3727 1340 |
About Marlowe plc
Marlowe is a leader in business-critical services which ensures compliance with strict regulations and insurance requirements across Fire Safety & Security and Water & Air Hygiene. The Group has a national footprint and serves approximately 27,000 customers across office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
